A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally-administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis
American Journal of Obstetrics and Gynecology | Mar 16, 2018
Impact of contraceptive initiation on vaginal microbiota
American Journal of Obstetrics and Gynecology | Mar 09, 2018
Most read this week